TR200100020T2 - Gliserol trinitrat içerikli bileşim, imalat yöntemleri ve kullanımı - Google Patents

Gliserol trinitrat içerikli bileşim, imalat yöntemleri ve kullanımı

Info

Publication number
TR200100020T2
TR200100020T2 TR2001/00020T TR200100020T TR200100020T2 TR 200100020 T2 TR200100020 T2 TR 200100020T2 TR 2001/00020 T TR2001/00020 T TR 2001/00020T TR 200100020 T TR200100020 T TR 200100020T TR 200100020 T2 TR200100020 T2 TR 200100020T2
Authority
TR
Turkey
Prior art keywords
composition
manufacturing methods
mass
glycerol trinitrate
content
Prior art date
Application number
TR2001/00020T
Other languages
English (en)
Inventor
Berthold Achim
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of TR200100020T2 publication Critical patent/TR200100020T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Gliserol trinitratin insan cildinden nüfuzu yoluyla bir organizmada transdermal terapi amaciyla uygulanmasi için kullanilan ve etki maddesi geçirmeyen bir arka tabakaya sahip poliakrilat bazli, kendiliginden yapisan bir tabakanin içinde etki maddesinin tedavi etkili payini içeren preparatin özelligi, -Etki maddesi içeren tabaka için poliakrilat bazli, kendiliginden yapisan bir kütlenin kullanilmasi, -Kütledeki vinil asetat konsantrasyonunun en fazla yüzde 6 agirlik payinda olmasi ve -Kütledeki etki maddesi konsantrasyonunun en fazla yüzde 25 agirlik payinda olmasidir.
TR2001/00020T 1998-07-09 1999-07-02 Gliserol trinitrat içerikli bileşim, imalat yöntemleri ve kullanımı TR200100020T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19830648A DE19830648A1 (de) 1998-07-09 1998-07-09 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
TR200100020T2 true TR200100020T2 (tr) 2001-07-23

Family

ID=7873427

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00020T TR200100020T2 (tr) 1998-07-09 1999-07-02 Gliserol trinitrat içerikli bileşim, imalat yöntemleri ve kullanımı

Country Status (15)

Country Link
EP (1) EP1094793A1 (tr)
JP (1) JP2002520268A (tr)
KR (1) KR20010074687A (tr)
CN (1) CN1308526A (tr)
AU (1) AU4781499A (tr)
BR (1) BR9911984A (tr)
CA (1) CA2336704A1 (tr)
DE (1) DE19830648A1 (tr)
HU (1) HUP0104950A3 (tr)
IL (1) IL140739A0 (tr)
MX (1) MXPA01000127A (tr)
PL (1) PL345545A1 (tr)
TR (1) TR200100020T2 (tr)
WO (1) WO2000002537A1 (tr)
ZA (1) ZA200100173B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045701A2 (en) * 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
JP5681883B2 (ja) * 2009-03-27 2015-03-11 株式会社 メドレックス 核酸を有効成分とする外用剤組成物
JP5816881B2 (ja) * 2014-05-21 2015-11-18 株式会社 メドレックス 核酸を有効成分とする外用剤組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤
ATE126434T1 (de) * 1991-06-10 1995-09-15 Sanol Arznei Schwarz Gmbh Nitroglycerin-pflaster und verfahren zu seiner herstellung.
ES2127711T1 (es) * 1996-12-10 1999-05-01 Rotta Res Bv Sistema de administracion transdermal de farmacos para el tratamiento de enfermedades del corazon.

Also Published As

Publication number Publication date
WO2000002537A1 (de) 2000-01-20
JP2002520268A (ja) 2002-07-09
BR9911984A (pt) 2001-03-27
PL345545A1 (en) 2001-12-17
AU4781499A (en) 2000-02-01
DE19830648A1 (de) 2000-01-13
CA2336704A1 (en) 2000-01-20
HUP0104950A3 (en) 2002-07-29
IL140739A0 (en) 2002-02-10
EP1094793A1 (de) 2001-05-02
MXPA01000127A (es) 2002-06-04
ZA200100173B (en) 2001-08-10
HUP0104950A2 (en) 2002-06-29
KR20010074687A (ko) 2001-08-09
CN1308526A (zh) 2001-08-15

Similar Documents

Publication Publication Date Title
ADRIANI et al. Penetration of local anesthetics through epithelial barriers
ES2171672T3 (es) Composiciones activadoras de penetracion en la piel mediante la utilizacion de lactilatos de acilo.
KR910016318A (ko) 이온 전기 도입법으로 딜리버리된 활성제의 피부내 농도를 증가시키는 방법 및 여기에 사용되는 조성물
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
BR0115392A (pt) Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga
TR200100022T2 (tr) Steroidal olmayan, asit gruplu romatizma ilacı içeren lokal etkili flaster
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
EP0164998A3 (en) Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
JP2004524327A5 (tr)
IL125088A0 (en) Modulation of TH1/TH2 cytokine expression
TR200100021T2 (tr) Kandaki yağ değerlerini etkileyen en az bir etki maddesine sahip bileşim
TR200100020T2 (tr) Gliserol trinitrat içerikli bileşim, imalat yöntemleri ve kullanımı
Weisshaar et al. Experimentally induced pruritus and cutaneous reactions with topical antihistamine and local analgesics in atopic eczema
WO2000000184A8 (en) Use of histamine h2 mimicking substances for the treatment of multiple sclerosis
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent
TR200000249T2 (tr) Bir etki maddesinin deri üzerinden bir organizmaya geçirilmesi ve deri üzerine tatbik işlemine dair transdermal terapötik sistem (TTS)
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
AR020815A1 (es) Procedimiento para el tratamiento de la esquizofrenia, como tambien medios para ser utilizados en dicho procedimiento
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
JPS6483024A (en) Cataplasm for cold
DK0776197T3 (da) TTS-estradiol med vandbindende additiver